Opened the debate
Jim Shannon is concerned about the impact of vitamin D deficiency on individuals' immune response to respiratory viruses, especially in light of the high levels of anxiety and depression prevalent during the pandemic. He points out that vitamin D can potentially mitigate the inflammatory response against respiratory viruses like SARS-CoV-2. Shannon highlights evidence from studies indicating that vitamin D supplementation significantly reduces ICU admissions and mortality rates among patients with covid-19 infections, suggesting a beneficial role for vitamin D. Furthermore, he expresses worry about high rates of vitamin D deficiency in black, Asian, and minority ethnic groups, which may contribute to higher mortality rates within these communities.